private digital health companies weight loss glp-1 Diet Works Companion, 60 CT GLP-1 Weight Loss Drugs: Impact

Its Phase 3 weight-loss figures (in the low-to-mid 20% range) and its late-2025 FDA filing belong to the combination product, not to standalone cagrilintide, which remains at the Phase 2 stage with a peer-reviewed monotherapy result of about 10.8% at 26 weeks

Carrot Fertility launches virtual menopause clinic

The GutMetabolism Connection Your gut plays a central role in metabolic regulation

PubMed Central, Femminella, Grazia Daniela, et al

Here are the approaches that have worked for her patients

In a recent preclinical study, scientists used a semaglutide-loaded microneedle patch in obese mice and observed comparable plasma drug concentrations to subcutaneous injection, along with improvements in glucose tolerance and reduced food intake